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Objectives. We sought to determine whether the antioxidant
vitamin C improves endothelium-dependent vasodilation of fore-
arm resistance vessels in patients with insulin-dependent diabetes
mellitus.
Background. Endothelium-dependent vasodilation is impaired
in patients with diabetes mellitus. Oxidatively mediated degrada-
tion of endothelium-derived nitric oxide contributes to abnormal
endothelium-dependent vasodilation in animal models of diabetes
mellitus.
Methods. The study group included 10 patients with insulin-
dependent diabetes mellitus and 10 age-matched control subjects.
Forearm blood flow was determined by venous occlusion plethys-
mography. Endothelium-dependent vasodilation was assessed by
intraarterial infusion of methacholine (0.3 to 10 mg/min).
Endothelium-independent vasodilation was assessed by intraar-
terial infusion of nitroprusside (0.3 to 10 mg/min). Forearm blood
flow dose–response curves were determined for each drug infusion
before and during concomitant infusion of vitamin C (24 mg/min).
Results. In diabetic subjects, endothelium-dependent vasodila-
tion was augmented by the concomitant infusion of vitamin C (p 5
0.001). Endothelium-independent vasodilation was not affected by
the concomitant infusion of vitamin C (p 5 NS). In control
subjects, vitamin C infusion did not affect endothelium-dependent
vasodilation (p 5 NS).
Conclusions. Vitamin C selectively restores the impaired
endothelium-dependent vasodilation in the forearm resistance
vessels of patients with insulin-dependent diabetes mellitus.
These findings indicate that nitric oxide degradation by oxygen-
derived free radicals contributes to abnormal vascular reactivity
in humans with insulin-dependent diabetes mellitus.
(J Am Coll Cardiol 1998;31:552–7)
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Patients with diabetes mellitus develop atherosclerotic vascular
disease earlier and with greater severity than nondiabetic
subjects (1–7). Approximately 35% of patients with insulin-
dependent diabetes mellitus die of coronary artery disease by
the age of 55 years (1). Endothelial dysfunction may occur
early in the process of atherogenesis and has been observed
before the development of overt atherosclerosis in patients
with diabetes (8–13).
The endothelium plays a critical role in regulating vascular
function, in part by the elaboration and release of nitric oxide.
Endothelium-derived nitric oxide reduces vascular resistance,
inhibits platelet and leukocyte adhesion to the vascular wall
and attenuates vascular smooth muscle proliferation (14–18).
Among the potential mechanisms contributing to endothelial
dysfunction in diabetic patients is inactivation of nitric oxide by
oxygen-derived free radicals. Indeed, studies in animal models
have demonstrated that administration of antioxidants restores
normal endothelial function (19–23).
The intent of the present study was to assess whether
oxygen-derived free radicals impair endothelial function in
humans with insulin-dependent diabetes mellitus. Vitamin C is
a water-soluble antioxidant capable of scavenging free radicals
and sparing other endogenous antioxidants from consumption
(24–27). Therefore, we tested the hypothesis that short-term
intraarterial administration of vitamin C could improve
endothelium-dependent vasodilation in patients with insulin-
dependent diabetes mellitus.
Methods
Subjects. The study group included 10 patients (4 men, 6
women; mean [6SD] age 34 6 8 years, range 22 to 48) with
insulin-dependent diabetes mellitus, as defined by the National
Diabetes Data Group criteria (28). The duration of diabetes
mellitus ranged from 1.7 to 31.0 years (mean 12.4 6 3.3). All
diabetic patients had a history of ketoacidosis and were
currently receiving insulin therapy. The study group also
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included 10 healthy volunteers (5 men, 5 women; mean age
34 6 10 years, range 20 to 48).
All subjects were recruited from the Boston area by means
of print advertisements. Each subject was screened by history,
physical examination and laboratory evaluation. Criteria for
exclusion for all subjects included hypertension (defined as a
blood pressure .140/90 mm Hg), history of tobacco use,
hypercholesterolemia (defined as low density lipoprotein cho-
lesterol .75th percentile for age and gender), cardiac or
pulmonary disease, serologic evidence of hepatic, hematologic
or renal dysfunction and any use of antihypertensive, cardiac,
vasoactive or antioxidant medications. The subjects had nei-
ther evidence of atherosclerotic disease as manifested by
angina or claudication nor physical findings of decreased
pulses, bruits or asymmetric blood pressures. All diabetic
patients had a fundoscopic examination and were screened for
proteinuria. No diabetic patient had evidence of neuropathy,
orthostatic hypotension, rest tachycardia or poor glycemic
control (defined as a glycosylated hemoglobin .9%). This
study was approved by the Human Research Committee of
Brigham and Women’s Hospital, and each subject gave written
informed consent.
Drug protocol. Methacholine chloride (Roche Laboratory,
Division of Hoffman-La Roche Inc.), a congener of acetylcho-
line, was infused through the brachial artery to assess
endothelium-dependent vasodilation. Forearm blood flow was
measured during escalating doses of methacholine at 0.3, 1.0,
3.0 and 10 mg/min. Sodium nitroprusside (Elkins-Sinn Inc.)
was infused through the brachial artery to assess the vasodila-
tor response to an exogenous nitric oxide donor. Forearm
blood flow was measured during increasing doses of sodium
nitroprusside at 0.3, 1.0, 3.0 and 10 mg/min. All drug infusions
were administered for 3 min at each dose at a rate of
0.4 ml/min. The drug doses were chosen to achieve a maximal
increase in local forearm blood flow without significant alter-
ations in systemic hemodynamic variables.
Vitamin C (sodium ascorbate, Abbott Laboratories) was
infused through the brachial artery to assess the effect of this
antioxidant on the vasodilator response to methacholine and
sodium nitroprusside. Vitamin C was infused at a constant
dose of 24 mg/min and a constant rate of 0.4 ml/min to limit the
cumulative dose of vitamin C to ,1,000 mg and to achieve a
local forearm concentration of 1 to 10 mmol/liter. This con-
centration of vitamin C has been shown to completely protect
human plasma from lipid peroxidation caused by free radical–
mediated peroxidation in vitro and to improve endothelium-
dependent vasodilation in non–insulin-dependent diabetic pa-
tients and smokers (26,29,30).
Experimental protocol. Each subject was studied in the
morning in a temperature-controlled room at 23°C in the
postabsorptive state. Alcohol and caffeine were withheld 12 h
before the study. Aspirin and nonsteroidal medications were
withheld 7 days before the study. All diabetic patients were
receiving conventional insulin therapy twice a day. Insulin was
held for the 12 h before the study; longer periods were avoided
because of the risk of ketoacidosis. Under local anesthesia and
using sterile technique, a 20-gauge polyethylene catheter was
inserted into the brachial artery for determination of blood
pressure and for administration of drugs.
At the beginning of each study protocol, normal saline
(0.9% sodium chloride) was infused intraarterially at a rate of
0.4 ml/min, and measurements of forearm blood flow and
blood pressure were obtained at 10-min intervals for a mini-
mum of 30 min until a baseline stable state was achieved. All
subjects underwent the following protocol: 1) intraarterial
administration of escalating doses of methacholine to define
the forearm blood flow dose–response relation; 2) a rest period
of at least 60 min to reestablish baseline forearm blood flow; 3)
infusion of vitamin C intraarterially for 10 min, with measure-
ment of forearm blood flow; and 4) a repeat forearm blood
flow dose–response curve to methacholine during concomitant
infusion of vitamin C. Using a similar protocol, five diabetic
patients underwent an additional protocol on a separate date
to determine the forearm blood flow dose–response relation
for sodium nitroprusside, before and during concomitant vita-
min C infusion. All drugs were administered at a constant
infusion rate of 0.4 ml/min.
Hemodynamic assessment. Bilateral forearm blood flow
was assessed by venous occlusion strain-gauge plethysmogra-
phy, using calibrated mercury-in-Silastic strain gauges, and
expressed as ml/100 ml tissue per min (D. E. Hokanson). Both
arms were supported above the level of the heart. Venous
occlusion pressure averaged 34 6 1 mm Hg. A wrist cuff was
inflated to suprasystolic pressures before each forearm blood
flow determination to prevent circulation to the hand. Each
forearm blood flow measurement comprised a minimum of five
separate determinations at 10- to 15-s intervals. The vascular
response to each drug was assessed by the forearm blood flow
in the drug infusion arm. To exclude a systemic response
during each drug infusion, forearm blood flow was simulta-
neously assessed in the contralateral arm. Forearm vascular
resistance was calculated as the ratio of mean blood pressure
to forearm blood flow and expressed as mm Hg/ml per 100 ml
tissue per min (U).
Blood pressure was assessed with the arterial cannula at-
tached to a Statham P23 pressure transducer that was aligned
to an amplifier on a physiologic recorder (Gould Inc.). Heart
rate determination was made from a simultaneous electrocar-
diographic signal and calculated from the RR interval.
Statistical analysis. Results are presented as mean value 6
SE. Unpaired and two-tailed t tests were used to assess the
differences in clinical characteristics between the diabetic and
nondiabetic subjects. Analysis of the dose–response curves for
each drug infusion before and during concomitant infusion of
vitamin C was performed using two-way analysis of variance
(ANOVA) for repeated measures. Comparisons of forearm
blood flow before and during concomitant infusion of vitamin
C for each drug dose were made using two-tailed t tests,
unpaired or paired as appropriate, and adjusted with a
Bonferonni correction for multiple comparisons. Statistical
significance was accepted at the 95% confidence level (p ,
0.05).
553JACC Vol. 31, No. 3 TIMIMI ET AL.
March 1, 1998:552–7 VITAMIN C AND ENDOTHELIAL DYSFUNCTION
Results
Subjects. The clinical characteristics of the study and con-
trol groups are presented in Table 1. Both groups were well
matched for age. No subject in either group had any evidence
of hypertension, hypercholesterolemia, tobacco use or cardio-
vascular disease. The mean blood pressure, blood urea nitro-
gen and serum creatinine were similar between the two groups.
The diabetic patients had significantly higher glucose, glycosy-
lated hemoglobin and insulin levels. No diabetic patients had
evidence of neuropathy. Three diabetic patients had evidence
of nonproliferative retinopathy by fundoscopic examination.
Basal forearm blood flow and vitamin C. Basal forearm
blood flow was comparable between diabetic patients and
control subjects (2.4 6 0.1 vs. 2.4 6 0.3 ml/100 ml tissue per
min, p 5 NS). Baseline forearm vascular resistance was 34.0 6
2.0 U in the patients with diabetes and 38.1 6 5.8 U in the
control subjects (p 5 NS). Intraarterial infusion of vitamin C
did not alter baseline forearm blood flow in either group (2.4 6
0.2 ml/100 ml tissue per min in diabetic patients vs. 2.1 6 0.2
ml/100 ml tissue per min in control subjects, p 5 NS).
Effect of vitamin C on endothelium-dependent vasodilation.
Methacholine increased forearm blood flow and decreased
forearm vascular resistance in both groups (Fig. 1). However,
the response to methacholine was significantly blunted in
diabetic patients compared with control subjects (p 5 0.001 by
ANOVA). At the peak dose of methacholine (10 mg/min),
forearm blood flow was 14.5 6 1.1 ml/100 ml tissue per min in
the diabetic patients compared with 23.0 6 1.3 ml/100 ml tissue
per min in the control subjects (p 5 0.005). Similarly, forearm
vascular resistance at the peak dose was higher in diabetic
patients (6.0 6 0.8 U) than in control subjects (3.5 6 0.2 U,
p 5 0.03). Methacholine infusion did not alter forearm blood
flow or forearm vascular resistance in the contralateral arm
and did not affect the systemic blood pressure or heart rate in
either group.
In patients with insulin-dependent diabetes mellitus, the
forearm blood flow response to methacholine was augmented
by concomitant infusion of vitamin C (p 5 0.001 by ANOVA)
(Fig. 2). At the peak dose of methacholine (10 mg/min),
forearm blood flow increased from 14.5 6 1.1 ml/100 ml tissue
per min before infusion of vitamin C to 20.6 6 1.8 ml/100 ml
tissue per min during vitamin C administration (p 5 0.005). At
the peak dose of methacholine (10 mg/min), forearm vascular
resistance decreased from 6.0 6 0.8 U before vitamin C to
4.2 6 0.5 U after it (p 5 0.04).
The forearm blood flow response to methacholine in con-
trol subjects was not changed by concomitant infusion of
vitamin C (p 5 NS by ANOVA) (Fig. 3). At the peak dose of
methacholine (10 mg/min), forearm blood flow before and
during infusion of vitamin C was 23.0 6 1.3 and 23.4 6 1.8
ml/100 ml tissue per min, respectively (p 5 NS). Similarly,
forearm vascular resistance was not altered by vitamin C (3.5 6
0.2 U before vs. 3.5 6 0.3 U during the infusion, p 5 NS).





Age (years) 34 6 2.7 34 6 3.2
Male/female 6/4 5/5
Body mass index (kg/m2) 25 6 1 24 6 1
Mean blood pressure (mm Hg) 80 6 4 78 6 3
Creatinine (mg/dl) 1 6 0.1 1 6 0.1
Total cholesterol (mg/dl) 173 6 6 168 6 8
HDL cholesterol (mg/dl) 43 6 2 42 6 2
LDL cholesterol (mg/dl) 115 6 6 109 6 7
Triglycerides (mg/dl) 70 6 9 92 6 12
Glucose (mg/dl) 185 6 20 83 6 4*
Glycosylated hemoglobin (%) 7.1 6 0.5 4.4 6 0.2*
Insulin (U/ml) 35.1 6 12.8 5.2 6 0.9†
*p 5 0.01 and †p 5 0.04 versus diabetic patients. Data presented are mean
value 6 SE. HDL 5 high density lipoprotein; LDL 5 low density lipoprotein.
Figure 1. Forearm blood flow (FBF) dose–response curves to metha-
choline in insulin-dependent diabetic patients (circles) and control
subjects (squares). The endothelium-dependent vasodilator response
was attenuated in diabetic patients compared with that in control
subjects (p 5 0.001 by ANOVA). *p 5 0.03, **p 5 0.04 and ***p 5
0.001, significant differences in forearm blood flow at each methacho-
line dose for diabetic patients versus nondiabetic subjects.
Figure 2. Forearm blood flow (FBF) dose–response curves to metha-
choline in insulin-dependent diabetic patients before (circles) and
during (squares) the infusion of vitamin C. The endothelium-
dependent vasodilatory response was augmented during the concom-
itant infusion of vitamin C (p 5 0.001 by ANOVA). *p 5 0.02, **p 5
0.04 and ***p 5 0.005, significant differences in forearm blood flow at
each methacholine dose before versus during vitamin C administra-
tion.
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Effect of vitamin C on endothelium-independent vasodila-
tion. In patients with insulin-dependent diabetes mellitus, the
forearm blood flow dose–response curve to sodium nitroprus-
side was not affected by the concomitant infusion of vitamin C
(p 5 NS by ANOVA) (Fig. 4). At the peak dose of sodium
nitroprusside (10 mg/min), forearm blood flow was 15.7 6 2.2
before and 15.8 6 2.8 ml/100 ml tissue per min during infusion
of vitamin C (p 5 NS). Forearm vascular resistance was 5.5 6
1.0 U before and 5.6 6 0.9 U during vitamin C infusion (p 5
NS). Sodium nitroprusside infusion did not alter forearm
blood flow or forearm vascular resistance in the contralateral
arm and did not affect systemic blood pressure or heart rate in
either group.
Discussion
The salient finding of this study is that short-term intraarte-
rial administration of the antioxidant vitamin C restores
endothelium-dependent vasodilation in patients with insulin-
dependent diabetes mellitus. Endothelium-independent vaso-
dilation was not affected by the infusion of vitamin C. In
nondiabetic control subjects, vitamin C had no effect on the
endothelium-dependent vasodilator response. These findings
suggest that oxygen-derived free radicals may decrease the
bioavailability of endothelium-derived nitric oxide and impair
endothelium-dependent vasodilation in patients with insulin-
dependent diabetes mellitus.
Endothelial dysfunction in diabetes mellitus. The vascular
endothelium in healthy subjects synthesizes and releases a
variety of substances that regulate vascular tone, including
nitric oxide (14–17). Endothelium-dependent vasodilation is
reduced in experimental models of diabetes mellitus (31–34).
Also, endothelium-dependent relaxation is reduced in arteries
isolated from nondiabetic animals exposed to a hyperglycemic
environment (20,35). Moreover, studies conducted in humans
with insulin-dependent as well as non–insulin-dependent dia-
betes mellitus have found impaired endothelium-dependent
vasodilation (9–13). Our study also confirms the observation
that endothelium-dependent vasodilation is impaired in pa-
tients with insulin-dependent diabetes mellitus. Potential fac-
tors contributing to this dysfunction include decreased synthe-
sis or release of endothelium-derived nitric oxide and
increased inactivation of endothelium-derived nitric oxide by
oxygen-derived free radicals.
Oxidant stress and endothelial dysfunction. Oxygen-
derived free radicals, particularly superoxide anions, inactivate
endothelium-derived nitric oxide (36–40). In animal models of
hypercholesterolemia, vascular production of superoxide an-
ions is increased and is causally related to impaired
endothelium-dependent relaxation (41–43). Treatment with
antioxidants restores endothelial function in these models
(40–42,44–46). Similarly, superoxide anions may inactivate
nitric oxide in diabetes mellitus (19–23). In animal models of
diabetes mellitus, the impairment in endothelium-dependent
relaxation can be improved by treatment with superoxide
dismutase (19–21,23).
There are several potential etiologies of oxidative stress in
diabetes mellitus. Oxidant production may be increased or
antioxidant defenses impaired, each leading to a greater
concentration of oxygen-derived free radicals. Production of
oxygen-derived free radicals is augmented in circulating gran-
ulocytes and monocytes from patients with diabetes, as well as
from nondiabetic subjects exposed to a hyperglycemic environ-
ment (47,48). Experimental hyperglycemia increases arachi-
donic acid metabolism and eicosanoid synthesis, which aug-
ment oxygen-derived free radical production (31,49,50). In
porcine vascular smooth muscle cells cultured in a hyperglyce-
mic environment, formation of F2-isoprostane (generated as a
product of peroxidation of arachidonic acid by free radicals) is
enhanced (51). Auto-oxidation of glucose, as catalyzed by
transition metals and glycosylation of proteins, can generate
oxygen-derived free radicals (52–54). Moreover, the activity of
the superoxide anion scavenger, superoxide dismutase, is de-
creased in rats with diabetes mellitus induced by streptozotocin
or alloxan monohydrate (55,56). In addition, studies have
shown decreased levels of vitamin C in diabetic patients,
despite adequate vitamin C intake (26,27,57–62), and in-
Figure 4. Forearm blood flow (FBF) dose–response curves to sodium
nitroprusside in diabetic patients before (circles) and during (squares)
the infusion of vitamin C. Endothelium-independent vasodilation was
not different during the concomitant infusion of vitamin C (p 5 NS by
ANOVA).
Figure 3. Forearm blood flow (FBF) dose–response curves to metha-
choline in control subjects before (circles) and during (squares) the
infusion of vitamin C. Endothelium-dependent vasodilation was not
different during the concomitant infusion of vitamin C (p 5 NS by
ANOVA).
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creased levels of oxidized metabolic products of ascorbic acid,
such as dehydroascorbic acid (63–65). Vitamin C is a potent
endogenous antioxidant in human plasma, capable of scaveng-
ing of oxygen-derived free radicals (24–27). In this manner,
vitamin C not only serves as an antioxidant, but also spares
other endogenous antioxidants from consumption.
We previously demonstrated (29) that vitamin C improves
endothelium-dependent vasodilation in patients with non–
insulin-dependent diabetes mellitus. Insulin-dependent diabe-
tes mellitus is clinically and pathologically different from
non–insulin-dependent diabetes mellitus. Insulin-dependent
diabetes mellitus is characteristically a disease of younger
patients and is typically associated with a lower body mass
index, ketotic prone metabolism and strict insulin requirement.
Non–insulin-dependent diabetes mellitus, in contrast, is the
result of insulin resistance. Non–insulin-dependent diabetes
mellitus typically affects older patients with a higher body mass
index and a higher incidence of hypertension and hypertriglyc-
eridemia than age-matched nondiabetic subjects. Although
both subsets of diabetes are characterized by premature ath-
erosclerosis, the prevalence of vascular disease varies consid-
erably between the two groups, with the risk of proliferative
retinopathy being twofold higher in insulin-dependent diabetic
patients at 20 years after diagnosis (66). Despite these meta-
bolic, clinical and pathologic differences, we found a common
reduction in endothelium-dependent vasodilation, as well as a
remarkably similar response to the early administration of the
antioxidant vitamin C (29). This finding suggests that the
imbalance between oxidative stress and antioxidant defenses
may be a common link in causing endothelial dysfunction in
these diverse patient groups.
Conclusions. In the current study, intraarterial administra-
tion of the antioxidant vitamin C restored endothelium-
dependent vasodilation in patients with insulin-dependent
diabetes mellitus. This result supports the notion that oxygen-
derived free radicals may contribute to abnormal vascular
function in patients with diabetes mellitus. It is not certain that
comparable effects would be observed after oral intake of
vitamin C, because comparable plasma concentrations would
be difficult to achieve. Further studies of the effects of long-
term oral antioxidant therapy on vascular function are war-
ranted as a means of reducing vascular disease in patients with
diabetes.
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